BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8245568)

  • 1. p53 and Ki 67 expression in preneoplastic and neoplastic lesions of the oral mucosa.
    Girod SC; Krueger G; Pape HD
    Int J Oral Maxillofac Surg; 1993 Oct; 22(5):285-8. PubMed ID: 8245568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
    Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 expression in oral precancer and cancer.
    Rich AM; Kerdpon D; Reade PC
    Aust Dent J; 1999 Jun; 44(2):103-5. PubMed ID: 10452165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of premalignant oral lesions.
    Mithani SK; Mydlarz WK; Grumbine FL; Smith IM; Califano JA
    Oral Dis; 2007 Mar; 13(2):126-33. PubMed ID: 17305612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD.
    Ogmundsdóttir HM; Hilmarsdóttir H; Astvaldsdóttir A; Jóhannsson JH; Holbrook WP
    Eur J Oral Sci; 2002 Jun; 110(3):192-8. PubMed ID: 12120703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
    Ogmundsdóttir HM; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 expression in the carcinogenesis in the oral mucosa.
    Girod SC; Krämer C; Knüfermann R; Krueger GR
    J Cell Biochem; 1994 Dec; 56(4):444-8. PubMed ID: 7890803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 and PCNA expression in carcinogenesis of the oropharyngeal mucosa.
    Girod SC; Pape HD; Krueger GR
    Eur J Cancer B Oral Oncol; 1994 Nov; 30B(6):419-23. PubMed ID: 7719225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial growth fraction and expression of p53 tumour suppressor gene in oral submucous fibrosis.
    Cox SC; Walker DM
    Aust Dent J; 1996 Apr; 41(2):91-6. PubMed ID: 8670041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical analysis of the p53 tumor suppressor gene product in oral leukoplakia].
    Kikegawa A
    Kokubyo Gakkai Zasshi; 2001 Mar; 68(1):51-9. PubMed ID: 11321806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation.
    Ebrahimi M; Wahlin YB; Coates PJ; Sjöström B; Nylander K
    J Oral Pathol Med; 2006 Jan; 35(1):46-50. PubMed ID: 16393253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
    Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
    J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the tumour suppressor gene p53 in oral cancer.
    Langdon JD; Partridge M
    Br J Oral Maxillofac Surg; 1992 Aug; 30(4):214-20. PubMed ID: 1380822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of p53 and Ki-67 genes in epithelial dysplasia from old oral mucosa and clinical significance].
    Zhao J; Guo B; Ma SC; Zhou XD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):689-91. PubMed ID: 16235539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of immunomodulatory mediators in oral precancerous lesions.
    Gonçalves AS; Mosconi C; Jaeger F; Wastowski IJ; Aguiar MCF; Silva TA; Ribeiro-Rotta RF; Costa NL; Batista AC
    Hum Immunol; 2017 Nov; 78(11-12):752-757. PubMed ID: 28941745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia.
    Sousa FA; Paradella TC; Carvalho YR; Rosa LE
    J Oral Sci; 2009 Mar; 51(1):117-21. PubMed ID: 19325208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expressions of PDCD5 and p53 in oral leukoplakia and oral squamous cell carcinoma].
    Zhao XY; Liu HW; Wei MJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):429-32. PubMed ID: 16086069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
    Shintani S; Yoshihama Y; Emilio AR; Matsumura T
    Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.